483 Roundup: Three Facilities Slammed for Various Deficiencies

Drug GMP Report
A A
The FDA issued Form 483s to three companies for an array of issues, such as poor recordkeeping and inadequate employee training.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $200.00